http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09110718-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afd115dec46c157d3739020ebd4d866b |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate | 1995-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15406028b02abb626bb2c496fd0ca315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_108f933f93996b2a386022be158904b3 |
| publicationDate | 1997-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H09110718-A |
| titleOfInvention | Ischemia-reperfusion liver injury therapeutic agent |
| abstract | (57) Abstract: A therapeutic agent for ischemia-reperfusion liver injury, which comprises human-derived antithrombin-III as an active ingredient. [Effect] Human-derived antithrombin-III has the effect of reducing biliary excretion and leakage of hepatic enzymes such as GPT in mammals suffering from ischemia-reperfusion liver injury. It is useful as a therapeutic agent for perfused liver disorders. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0115723-A1 |
| priorityDate | 1995-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 110.